Skip to main content
Top
Published in: Hereditary Cancer in Clinical Practice 1/2011

Open Access 01-12-2011 | Research

How do women at increased, but unexplained, familial risk of breast cancer perceive and manage their risk? A qualitative interview study

Authors: Louise A Keogh, Belinda J McClaren, Carmel Apicella, John L Hopper, the Australian Breast Cancer Family Study

Published in: Hereditary Cancer in Clinical Practice | Issue 1/2011

Login to get access

Abstract

Background

The perception of breast cancer risk held by women who have not had breast cancer, and who are at increased, but unexplained, familial risk of breast cancer is poorly described. This study aims to describe risk perception and how it is related to screening behaviour for these women.

Methods

Participants were recruited from a population-based sample (the Australian Breast Cancer Family Study - ABCFS). The ABCFS includes women diagnosed with breast cancer and their relatives. For this study, women without breast cancer with at least one first- or second-degree relative diagnosed with breast cancer before age 50 were eligible unless a BRCA1 or BRCA2 mutation had been identified in their family. Data collection consisted of an audio recorded, semi-structured interview on the topic of breast cancer risk and screening decision-making. Data was analysed thematically.

Results

A total of 24 interviews were conducted, and saturation of the main themes was achieved. Women were classified into one of five groups: don't worry about cancer risk, but do screening; concerned about cancer risk, so do something; concerned about cancer risk, so why don't I do anything?; cancer inevitable; cancer unlikely.

Conclusions

The language and framework women use to describe their risk of breast cancer must be the starting point in attempts to enhance women's understanding of risk and their prevention behaviour.
Literature
1.
go back to reference Clarke A, Shim J, Mamo L, Fosket J, Fishman J: Biomedicalization: technoscientific transformations of health, illness, and US biomedicine. American Sociological Review 2003, 68: 161–194. 10.2307/1519765CrossRef Clarke A, Shim J, Mamo L, Fosket J, Fishman J: Biomedicalization: technoscientific transformations of health, illness, and US biomedicine. American Sociological Review 2003, 68: 161–194. 10.2307/1519765CrossRef
2.
go back to reference Scott S, Prior L, Wood F, Gray J: Repositioning the patient: the implications of being 'at risk'. Social Science & Medicine 2005, 60: 1869–1879. 10.1016/j.socscimed.2004.08.020CrossRef Scott S, Prior L, Wood F, Gray J: Repositioning the patient: the implications of being 'at risk'. Social Science & Medicine 2005, 60: 1869–1879. 10.1016/j.socscimed.2004.08.020CrossRef
3.
go back to reference Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van Â't Veer L, Garber JE, Evans GR, Narod SA, Isaacs C, Matloff E, et al.: Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group. Journal of Clinical Oncology 2004, 22: 1055–1062. 10.1200/JCO.2004.04.188CrossRefPubMed Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van Â't Veer L, Garber JE, Evans GR, Narod SA, Isaacs C, Matloff E, et al.: Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group. Journal of Clinical Oncology 2004, 22: 1055–1062. 10.1200/JCO.2004.04.188CrossRefPubMed
4.
go back to reference Rebbeck TR, Kauff ND, Domchek SM: Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers. Journal of the National Cancer Institute 2009, 101: 80–87. 10.1093/jnci/djn442CrossRefPubMedPubMedCentral Rebbeck TR, Kauff ND, Domchek SM: Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers. Journal of the National Cancer Institute 2009, 101: 80–87. 10.1093/jnci/djn442CrossRefPubMedPubMedCentral
5.
go back to reference Nelson HD, Fu R, Griffin JC, Nygren P, Smith MEB, Humphrey L: Systematic Review: Comparative Effectiveness of Medications to Reduce Risk for Primary Breast Cancer. Annals of Internal Medicine 2009, 151: 703–715.CrossRefPubMed Nelson HD, Fu R, Griffin JC, Nygren P, Smith MEB, Humphrey L: Systematic Review: Comparative Effectiveness of Medications to Reduce Risk for Primary Breast Cancer. Annals of Internal Medicine 2009, 151: 703–715.CrossRefPubMed
6.
go back to reference Arden-Jones A, Kenen R, Lynch E, Doherty R, Eeles R: Is no news good news? Inconclusive genetic test results in BRCA1 and BRCA2 from patients and professionals' perspectives. Hereditary Cancer in Clinical Practice 2010., 8: Arden-Jones A, Kenen R, Lynch E, Doherty R, Eeles R: Is no news good news? Inconclusive genetic test results in BRCA1 and BRCA2 from patients and professionals' perspectives. Hereditary Cancer in Clinical Practice 2010., 8:
7.
go back to reference Hawkes G, Rowe G: A characterisation of the methodology of qualitative research on the nature of perceived risk: trends and omissions. Journal of Risk Research 2008, 11: 617–643. 10.1080/13669870701875776CrossRef Hawkes G, Rowe G: A characterisation of the methodology of qualitative research on the nature of perceived risk: trends and omissions. Journal of Risk Research 2008, 11: 617–643. 10.1080/13669870701875776CrossRef
8.
go back to reference Pilarski R: Risk perception among women at risk for hereditary breast and ovarian cancer. Journal of Genetic Counselling 2009, 18: 303–312. 10.1007/s10897-009-9227-yCrossRef Pilarski R: Risk perception among women at risk for hereditary breast and ovarian cancer. Journal of Genetic Counselling 2009, 18: 303–312. 10.1007/s10897-009-9227-yCrossRef
9.
go back to reference Lee S: Uncertain futures: Individual risk and social context in decision-making in cancer screening. Health, Risk & Society 2010, 12: 110–117. Lee S: Uncertain futures: Individual risk and social context in decision-making in cancer screening. Health, Risk & Society 2010, 12: 110–117.
10.
go back to reference Collins DL, Street RL Jr: A dialogic model of conversations about risk: Coordinating perceptions and achieving quality decisions in cancer care. Social Science & Medicine 2009, 68: 1506–1512. 10.1016/j.socscimed.2009.01.016CrossRef Collins DL, Street RL Jr: A dialogic model of conversations about risk: Coordinating perceptions and achieving quality decisions in cancer care. Social Science & Medicine 2009, 68: 1506–1512. 10.1016/j.socscimed.2009.01.016CrossRef
11.
go back to reference Sanders T, Campbell R, Donovan J, Sharp D: Narrative accounts of hereditary risk: knowledge about family history, lay theories of disease, and 'internal' and 'external' causation. Qualitative Health Research 2007, 17: 510–520. 10.1177/1049732306297882CrossRefPubMed Sanders T, Campbell R, Donovan J, Sharp D: Narrative accounts of hereditary risk: knowledge about family history, lay theories of disease, and 'internal' and 'external' causation. Qualitative Health Research 2007, 17: 510–520. 10.1177/1049732306297882CrossRefPubMed
12.
go back to reference Linnenbringer E, Roberts J, Hiraki S, Cupples L, Green R: "I know what you told me, but this is what I think:" Perceived risk of Alzheimer disease among individuals who accurately recall their genetics-based risk estimate. Genetics in Medicine 2010, 12: 219–227.CrossRefPubMedPubMedCentral Linnenbringer E, Roberts J, Hiraki S, Cupples L, Green R: "I know what you told me, but this is what I think:" Perceived risk of Alzheimer disease among individuals who accurately recall their genetics-based risk estimate. Genetics in Medicine 2010, 12: 219–227.CrossRefPubMedPubMedCentral
13.
go back to reference Durfy SJ, Bowen DJ, McTiernan A, Sporleder J, Burke W: Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. Cancer Epidemiology Biomarkers and Prevention 1999, 8: 369–375. Durfy SJ, Bowen DJ, McTiernan A, Sporleder J, Burke W: Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. Cancer Epidemiology Biomarkers and Prevention 1999, 8: 369–375.
14.
go back to reference Woloshin S, Schwartz LM, Black WC, Welch HG: Women's perceptions of breast cancer risk: how you ask matters. Med Decis Making 1999, 19: 221–229. 10.1177/0272989X9901900301CrossRefPubMed Woloshin S, Schwartz LM, Black WC, Welch HG: Women's perceptions of breast cancer risk: how you ask matters. Med Decis Making 1999, 19: 221–229. 10.1177/0272989X9901900301CrossRefPubMed
15.
go back to reference Meiser B, Butow P, Barratt A, Gattas M, Gaff C, Haan E, Gleeson M, Dudding T, Tucker K, Group TPIC: Risk perception and knowledge of breast cancer genetics in women at increased risk of developing hereditary breast cacner. Psychology and Health 2001, 16: 297–311. 10.1080/08870440108405508CrossRef Meiser B, Butow P, Barratt A, Gattas M, Gaff C, Haan E, Gleeson M, Dudding T, Tucker K, Group TPIC: Risk perception and knowledge of breast cancer genetics in women at increased risk of developing hereditary breast cacner. Psychology and Health 2001, 16: 297–311. 10.1080/08870440108405508CrossRef
16.
go back to reference van Dijk S, Otten W, van Asperen CJ, Timmermans DR, Tibben A, Zoeteweij MW, Silberg S, Breuning MH, Kievit J: Feeling at risk: how women interpret their familial breast cancer risk. Am J Med Genet A 2004, 131: 42–49.CrossRefPubMed van Dijk S, Otten W, van Asperen CJ, Timmermans DR, Tibben A, Zoeteweij MW, Silberg S, Breuning MH, Kievit J: Feeling at risk: how women interpret their familial breast cancer risk. Am J Med Genet A 2004, 131: 42–49.CrossRefPubMed
17.
go back to reference Sheinfeld Gorin S, Albert SM: The meaning of risk to first degree relatives of women with breast cancer. Women and Health 2003, 37: 97–117. 10.1300/J013v37n03_07CrossRefPubMed Sheinfeld Gorin S, Albert SM: The meaning of risk to first degree relatives of women with breast cancer. Women and Health 2003, 37: 97–117. 10.1300/J013v37n03_07CrossRefPubMed
18.
go back to reference Salant T, Ganschow PS, Olopade OI, Lauderdale DS: "Why take it if you don't have anything?" breast cancer risk perceptions and prevention choices at a public hospital. J Gen Intern Med 2006, 21: 779–785. 10.1111/j.1525-1497.2006.00461.xCrossRefPubMedPubMedCentral Salant T, Ganschow PS, Olopade OI, Lauderdale DS: "Why take it if you don't have anything?" breast cancer risk perceptions and prevention choices at a public hospital. J Gen Intern Med 2006, 21: 779–785. 10.1111/j.1525-1497.2006.00461.xCrossRefPubMedPubMedCentral
19.
go back to reference Ozanne EM, Wittenberg E, Garber JE, Weeks JC: Breast cancer prevention: patient decision making and risk communication in the high risk setting. Breast J 2010, 16: 38–47. 10.1111/j.1524-4741.2009.00857.xCrossRefPubMed Ozanne EM, Wittenberg E, Garber JE, Weeks JC: Breast cancer prevention: patient decision making and risk communication in the high risk setting. Breast J 2010, 16: 38–47. 10.1111/j.1524-4741.2009.00857.xCrossRefPubMed
20.
go back to reference Sivell S, Elwyn G, Gaff CL, Clarke AJ, Iredale R, Shaw C, Dundon J, Thornton H, Edwards A: How risk is perceived, constructed and interpreted by clients in clinical genetics, and the effects on decision making: systematic review. J Genet Couns 2008, 17: 30–63. 10.1007/s10897-007-9132-1CrossRefPubMed Sivell S, Elwyn G, Gaff CL, Clarke AJ, Iredale R, Shaw C, Dundon J, Thornton H, Edwards A: How risk is perceived, constructed and interpreted by clients in clinical genetics, and the effects on decision making: systematic review. J Genet Couns 2008, 17: 30–63. 10.1007/s10897-007-9132-1CrossRefPubMed
21.
go back to reference Kenen R, Ardern-Jones A, Eeles R: Living with chronic risk: healthy women with a family history of breast/ovarian cancer. Health, Risk & Society 2003, 5: 315–331. 10.1080/13698570310001607003CrossRef Kenen R, Ardern-Jones A, Eeles R: Living with chronic risk: healthy women with a family history of breast/ovarian cancer. Health, Risk & Society 2003, 5: 315–331. 10.1080/13698570310001607003CrossRef
22.
go back to reference Tinley ST, Houfek J, Watson P, Wenzel L, Clark MB, Coughlin S, Lynch HT: Screening adherence in BRCA1/2 families is associated with primary physicians' behavior. Am J Med Genet A 2004, 125A: 5–11. 10.1002/ajmg.a.20431CrossRefPubMed Tinley ST, Houfek J, Watson P, Wenzel L, Clark MB, Coughlin S, Lynch HT: Screening adherence in BRCA1/2 families is associated with primary physicians' behavior. Am J Med Genet A 2004, 125A: 5–11. 10.1002/ajmg.a.20431CrossRefPubMed
23.
go back to reference Hamilton R, Williams J, Bowers B, Calzone K: Life trajectories, genetic testing, and risk reduction decisions in 18–39 year old women at risk for hereditary breast and ovarian cancer. Journal of Genetic Counselling 2009, 18: 147–159. 10.1007/s10897-008-9200-1CrossRef Hamilton R, Williams J, Bowers B, Calzone K: Life trajectories, genetic testing, and risk reduction decisions in 18–39 year old women at risk for hereditary breast and ovarian cancer. Journal of Genetic Counselling 2009, 18: 147–159. 10.1007/s10897-008-9200-1CrossRef
24.
go back to reference Meiser B, Halliday JL: What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review. Soc Sci Med 2002, 54: 1463–1470. 10.1016/S0277-9536(01)00133-2CrossRefPubMed Meiser B, Halliday JL: What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review. Soc Sci Med 2002, 54: 1463–1470. 10.1016/S0277-9536(01)00133-2CrossRefPubMed
25.
go back to reference Braithwaite D, Emery J, Walter F, Prevost AT, Sutton S: Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis. J Natl Cancer Inst 2004, 96: 122–133. 10.1093/jnci/djh017CrossRefPubMed Braithwaite D, Emery J, Walter F, Prevost AT, Sutton S: Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis. J Natl Cancer Inst 2004, 96: 122–133. 10.1093/jnci/djh017CrossRefPubMed
26.
go back to reference Tilburt J, James K, Sinicrope P, Eton D, Costello B, Carey J, Lane M, Ehlers S, Erwin P, Nowakowski K, Murad M: Factors Influencing Cancer Risk Perception in High Risk Populations: A Systematic Review. Hereditary Cancer in Clinical Practice 2011, 9: 2. 10.1186/1897-4287-9-2CrossRefPubMedPubMedCentral Tilburt J, James K, Sinicrope P, Eton D, Costello B, Carey J, Lane M, Ehlers S, Erwin P, Nowakowski K, Murad M: Factors Influencing Cancer Risk Perception in High Risk Populations: A Systematic Review. Hereditary Cancer in Clinical Practice 2011, 9: 2. 10.1186/1897-4287-9-2CrossRefPubMedPubMedCentral
27.
go back to reference Zinn J: The biographical approach: a better way to understand behaviour in health and illness. Health, Risk & Society 2005, 7: 1–9. 10.1080/13698570500042348CrossRef Zinn J: The biographical approach: a better way to understand behaviour in health and illness. Health, Risk & Society 2005, 7: 1–9. 10.1080/13698570500042348CrossRef
28.
go back to reference Silverman E, Woloshin S, Schwartz LM, Byran SJ, Welch HG, Fischhoff B: Women's views on breast cancer risk and screening mammography: A qualitative interview study. Medical Decision Making 2001, 21: 231–240.CrossRefPubMed Silverman E, Woloshin S, Schwartz LM, Byran SJ, Welch HG, Fischhoff B: Women's views on breast cancer risk and screening mammography: A qualitative interview study. Medical Decision Making 2001, 21: 231–240.CrossRefPubMed
29.
go back to reference Salant T, Gehlert S: Collective memory, candidacy, and victimisation: community epidemiologies of breast cancer risk. Sociology of Health and Illness 2008, 30: 599–615. 10.1111/j.1467-9566.2007.01079.xCrossRefPubMed Salant T, Gehlert S: Collective memory, candidacy, and victimisation: community epidemiologies of breast cancer risk. Sociology of Health and Illness 2008, 30: 599–615. 10.1111/j.1467-9566.2007.01079.xCrossRefPubMed
30.
go back to reference Spector D, Mishel M, Skinner CS, Deroo LA, Vanriper M, Sandler DP: Breast cancer risk perception and lifestyle behaviors among White and Black women with a family history of the disease. Cancer Nurs 2009, 32: 299–308. 10.1097/NCC.0b013e31819deab0CrossRefPubMedPubMedCentral Spector D, Mishel M, Skinner CS, Deroo LA, Vanriper M, Sandler DP: Breast cancer risk perception and lifestyle behaviors among White and Black women with a family history of the disease. Cancer Nurs 2009, 32: 299–308. 10.1097/NCC.0b013e31819deab0CrossRefPubMedPubMedCentral
31.
go back to reference Facione NC: Perceived risk of breast cancer: influence of heuristic thinking. Cancer Practice 2002, 10: 256–262. 10.1046/j.1523-5394.2002.105005.xCrossRefPubMed Facione NC: Perceived risk of breast cancer: influence of heuristic thinking. Cancer Practice 2002, 10: 256–262. 10.1046/j.1523-5394.2002.105005.xCrossRefPubMed
32.
go back to reference QSR International Pty Ltd Eighth edition. 2008. QSR International Pty Ltd Eighth edition. 2008.
33.
go back to reference Bennett P, Parsons E, Brain K, Hood K: Long-term cohort study of women at intermediate risk of familial breast cancer: experiences of living at risk. Psychooncology 2010, 19: 390–398. 10.1002/pon.1588CrossRefPubMed Bennett P, Parsons E, Brain K, Hood K: Long-term cohort study of women at intermediate risk of familial breast cancer: experiences of living at risk. Psychooncology 2010, 19: 390–398. 10.1002/pon.1588CrossRefPubMed
34.
go back to reference Parsons E, Atkinson P: Lay constructions of genetic risk. Sociology of Health and Illness 1992, 14: 437–455.CrossRef Parsons E, Atkinson P: Lay constructions of genetic risk. Sociology of Health and Illness 1992, 14: 437–455.CrossRef
35.
go back to reference Robertson A: Embodying risk, embodying political rationality: women's accounts of risks for breast cancer. Health, Risk & Society 2000, 2: 220–235.CrossRef Robertson A: Embodying risk, embodying political rationality: women's accounts of risks for breast cancer. Health, Risk & Society 2000, 2: 220–235.CrossRef
36.
go back to reference Lipworth WL, Davey HM, Carter SM, Hooker C, Hu W: Beliefs and beyond: what can we learn from qualitative studies of lay people's understanding of cancer risk? Health Expectations 2010, 13: 113–124.CrossRefPubMed Lipworth WL, Davey HM, Carter SM, Hooker C, Hu W: Beliefs and beyond: what can we learn from qualitative studies of lay people's understanding of cancer risk? Health Expectations 2010, 13: 113–124.CrossRefPubMed
Metadata
Title
How do women at increased, but unexplained, familial risk of breast cancer perceive and manage their risk? A qualitative interview study
Authors
Louise A Keogh
Belinda J McClaren
Carmel Apicella
John L Hopper
the Australian Breast Cancer Family Study
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Hereditary Cancer in Clinical Practice / Issue 1/2011
Electronic ISSN: 1897-4287
DOI
https://doi.org/10.1186/1897-4287-9-7

Other articles of this Issue 1/2011

Hereditary Cancer in Clinical Practice 1/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine